Varian Medical Systems ( VAR +2.4% ) fiscal Q3 results : Total Revenues: $747.7M (+3 ..... Q4 Guidance : Revenue growth: 7 - 15%; EPS: $1.14 - 1.29. VAR shares are down 3% AH on modest volume. Post your comment!
Varian Medical Systems (NYSE: VAR ): FQ3 EPS of $1.02 misses by $0.07 . Revenue of $747.7M (+3.0% Y/Y) misses by $19.82M . Press Release Post your comment!
The FDA issues 510(k) approval to Varian Medical Systems ' ( VAR -0.9% ) Calypso soft tissue Beacon transponder. The grain of rice-size transponder can be implanted throughout the body
Varian Medical Systems reported second-quarter results that ..... remain intact; we continue to believe Varian is well positioned to capitalize on its ..... RapidPlan are enjoying strong uptake. Varian also appears to be benefiting from the
long-term returns in Varian 's U.S. operations ..... regulatory risk surrounds Varian 's products. The path ..... to overall revenue. Varian is the market leader ..... InfiMed and Calypso. Varian Medical Systems designs, manufactures
Varian Medical Systems reported fairly weak fiscal fourth-quarter ..... remain intact; we continue to believe Varian is well positioned to capitalize on its ..... implications provided additional headwinds to Varian 's North American operations, as gross
Oct 23 (Reuters) - Medical device maker Varian Medical Systems Inc reported lower-than-expected fourth-quarter results as demand for its products fell due to uncertainties related to U.S. healthcare...
Varian Medical 's VAR third-quarter fiscal 2006 results fall ..... demand continues to reflect a shift toward Varian 's next-generation IGRT technology ..... its 37% order growth in the quarter. Varian 's flat panel products continue to encounter
Varian VAR reported fiscal first-quarter results ..... our last update and remain confident in Varian 's long-term outlook. Overall, first-quarter ..... can be lumpy and we remain confident in Varian 's overall competitive positioning despite
Varian Medical Systems VAR reported better-than-expected fourth-quarter ..... which we view as similarly encouraging. Varian was also active on the buyback front ..... ending fiscal 2012 on a strong note. Varian 's initial 2013 outlook calls for revenue